Status:
UNKNOWN
Measuring Response to Depression Treatment
Lead Sponsor:
Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.
Collaborating Sponsors:
AstraZeneca
Conditions:
Depression
Eligibility:
All Genders
19-65 years
Brief Summary
The primary goal of this study is to compare a new symptoms rating questionnaire, called the Vancouver Semi-Structured Interview for Depression (V-SID), to the traditionally used questionnaires. The i...
Detailed Description
Depression is sometimes associated with difficulties in thinking skills. Recent evidence suggests that in those people who have thinking difficulties, effective treatment and improvement of depression...
Eligibility Criteria
Inclusion
- Major depressive episode, diagnosed using the Mini-International Neuropsychiatric Interview (MINI)
- Depression not currently effectively treated
- Age 19 to 65 years
Exclusion
- Co-morbid Axis I disorders (co-morbid anxiety symptoms, including generalized anxiety or panic attacks, are not exclusionary if they are present in the context of a primary mood disorder)
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2011
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00924183
Start Date
June 1 2008
End Date
July 1 2011
Last Update
March 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Copeman Neuroscience Centre
Vancouver, British Columbia, Canada, V6Z 2L4